Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2022 08:05 ET | Source: Palisade Bio, Inc.

Palisade Bio Provides Update on U.S. Phase 2 Study Evaluating LB1148 for Post-Surgical Abdominal Adhesions

Topline data readout from study expected in first half of 2023 Carlsbad, CA, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company...
April 08, 2021 07:30 ET | Source: The Insight Partners

Gastroparesis Market Growth Steady at 4.3% CAGR to Reach $6,025.11 Million by 2027: COVID-19 Impact and Global Analysis by The Insight Partners

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) -- According to our new research study on “Gastroparesis Market to 2027 – Global Analysis and Forecast – by Gastroparesis Type, Drug Class Type, and...
April 26, 2019 08:00 ET | Source: Endonovo Therapeutics, Inc.

Endonovo Therapeutics Provides Corporate Update

LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...